Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

Pancreatic ductal adenocarcinoma (PDAC) is an extraordinarily lethal disease, which, despite a more or less efficient chemotherapeutic treatment, systematically displays a rapid and uncontrolled progression towards a fatal recurrence. Determining which cells give rise to such tumor recurrence is thu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoscience
Glavni autori: Molejon, Maria Inés, Tellechea, Juan Ignacio, Moutardier, Vincent, Gasmi, Mohamed, Ouaissi, Mehdi, Turrini, Olivier, Delpero, Jean-Robert, Dusetti, Nelson, Iovanna, Juan
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Perspective
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4506359/
https://ncbi.nlm.nih.gov/pubmed/26244163
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items